ADH, Free Water Regulation, and ADH-Active Drugs
USMLE Step 1 trap: Confuses V1 (Gq/vasoconstriction) and V2 (Gs/cAMP/AQP2) receptor signaling pathways. V2 receptors signal through Gs → cAMP → PKA (water reabsorption), while V1 receptors signal through Gq → IP3/DAG → vasoconstriction.
ADH (vasopressin) is one of the highest-yield renal physiology concepts on USMLE Step 1 — it connects osmoregulation, collecting duct physiology, clinical syndromes like SIADH and diabetes insipidus, and pharmacology all in one framework. The exam tests it at every level: pure recall (which receptor uses cAMP?), clinical application (why is the urine concentrated in SIADH?), and passage interpretation (a patient with head trauma and dilute polyuria — central or nephrogenic DI?). You need to own the entire axis from osmoreceptor firing in the hypothalamus → posterior pituitary ADH release → V2 receptor in collecting duct → Gs/cAMP/PKA → AQP2 insertion → water reabsorption.
What trips students up most is compartmentalizing this topic incorrectly. They memorize 'ADH = water retention' but then misapply it when they hit a SIADH question and can't figure out why the urine is concentrated while the plasma is dilute. They confuse V1 and V2 signaling, conflating both with cAMP. They also fumble the DI distinction because they think measuring ADH in blood solves the problem — it doesn't, because the key question is whether the kidney *responds* to ADH, not just whether it's present. USMLE Step 1 loves to exploit these exact blind spots.
The pharmacology layer (desmopressin vs. vaptans) is tested in the context of clinical indications, so you need to understand mechanism before memorizing drug names. Desmopressin is a V2-selective agonist — useful in central DI and certain bleeding disorders (it also releases vWF/factor VIII). Vaptans (conivaptan, tolvaptan) are V2 antagonists used in euvolemic or hypervolemic hyponatremia like SIADH. Free water clearance ties the whole concept together quantitatively and shows up in both calculation and interpretation formats on Step 1.
Common misconceptions
What the exam tests
- Trace the complete regulatory axis: how a rise in plasma osmolality activates hypothalamic osmoreceptors, triggers ADH release from the posterior pituitary, and drives V2 receptor-mediated AQP2 insertion in the collecting duct.
- Distinguish V1 from V2 receptor signaling: V2 couples to Gs → cAMP → PKA (water reabsorption in collecting duct), while V1 couples to Gq → IP3/DAG (vascular smooth muscle contraction), and explain why desmopressin is V2-selective.
- Identify the SIADH diagnostic profile: hyponatremia with inappropriately concentrated urine (Uosm > 100 mOsm/kg), low plasma osmolality, and euvolemia — and recognize common triggers like CNS disease, pulmonary disease, and medications (SSRIs, carbamazepine, cyclophosphamide).
- Distinguish central DI from nephrogenic DI using the water deprivation test with desmopressin challenge: central DI responds with urine concentration after desmopressin; nephrogenic DI does not respond because the kidney is resistant to ADH.
- Choose the correct ADH-active drug for a given scenario: desmopressin for central DI or bleeding disorders (vWF/factor VIII release), vaptans (V2 antagonists) for SIADH or other euvolemic/hypervolemic hyponatremia states.
- Interpret free water clearance (CH2O = V − Cosm): a negative value means the kidney is retaining free water (concentrated urine, as in SIADH); a positive value means free water is being excreted (dilute urine, as in DI).
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →